Navigation Links
In fight against cancer, a closer look at nuclear blebbing
Date:2/19/2013

Misshapen cell nuclei are frequently observed in the cells of people with cancer and other diseases, but what causes the abnormality -- and why it is associated with certain disorders -- has remained unclear.

Researchers at Northwestern University have recently developed a mathematical model that sheds light on the defect by clarifying the mechanisms that cause bulges known as "blebs" in cells' nuclear membranes. The research -- a collaboration between experts at the McCormick School of Engineering and Applied Science and the Feinberg School of Medicine -- could be a step toward bleb prevention, which may ultimately provide potential therapies for related diseases.

A paper describing the research, titled "Mechanical Model of Blebbing in Nuclear Lamin Meshworks," was published Feb. 11 in the Proceedings of the National Academy of Sciences USA (PNAS).

"Changes in the shape of the nucleus are indicative of a range of pathologies, including the premature aging disorder Hutchinson-Gilford progeria syndrome, EmeryDreifuss muscular dystrophy and some cancers," said Monica Olvera de la Cruz, the corresponding author of the paper. "Our research suggests that blebbing may be the result of an imbalance between the various proteins that constitute the nuclear lamina."

She is a Lawyer Taylor Professor, professor of materials science and engineering in the McCormick School and professor of chemistry in the Weinberg College of Arts and Sciences.

The nucleus -- the control center of the cell, the keeper of genetic material and overseer of cell growth and reproduction -- is covered by a nuclear envelope consisting of a double membrane and an underlying structure called the nuclear lamina that surrounds the surface of the nucleus and gives it shape. In addition to its mechanical support, the lamina helps regulate cell division and organize genetic material.

In the majority of healthy cells, the nucleus appears smooth and maintains an overall spherical shape, but abnormal nuclear shapes characterized by blebs have been observed in the cells of people suffering from some forms of cancer and other diseases.

In mammals, the lamin meshworks that make up the nuclear lamina consist of mainly two types of lamin proteins, known as types A and B, which are wrapped like two nets around the nucleus. Under normal conditions, the A-type and B-type lamins co-exist throughout the sphere, creating a healthy lamina of approximately even thickness throughout.

But when one of the B-type lamins is depleted, researchers found the A-type and B-type lamins begin to segregate from one another, resulting in an uneven mesh layer with altered mechanical properties. In some regions, the lamina's fibers begin to gap and separate, giving rise to nuclear blebs, bulges in the cell's nuclear envelope.

The nuclear lamins, especially the A-type lamins, are now considered to be major building blocks of nuclear architecture and are thus involved in numerous important nuclear functions. Much of the recent information on the functions of the nuclear lamins comes from findings demonstrating that many different human diseases are caused by hundreds of mutations in the nuclear lamin A gene. Many of these diseases are accompanied by changes in nuclear shape and altered lamin organization.

"This study helps us to begin to understand how these abnormal shapes are formed," said Robert D. Goldman, the Stephen Walter Ranson Professor of Cell and Molecular Biology, chair of the department of cell and molecular biology at the Feinberg School, and one of the paper's authors. "Collaborations between physicists and cell biologists are beginning to reveal new insights into these normal and abnormal cells."

Enabling some of those new insights, the Northwestern researchers designed an energy-minimizing continuum elastic model that enabled them to produce structures with comparable shapes and patterns as those found in naturally occurring pathological nuclei.


'/>"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
Source:Eurekalert

Related medicine news :

1. Research Foundation for Tick-Borne Infections Fights Lyme Disease, Babesiosis and Encephalitis with Pilot Studies
2. Combo of Avastin, second drug shows promise fighting brain cancer, Mayo Clinic finds
3. Report Calls for Better U.S. Efforts to Fight Counterfeit Drugs
4. New hope in fight against multi-resistant germs
5. WeightLossApp.com: The Skinny: Fighting Obesity in the Workplace Through an Innovative Mobile Application
6. Tiger Schulmann's MMA Student, Uriah Hall, Debuts on The Ultimate Fighter
7. Scientists Explore How Zinc Fights Off Infection
8. Electrical Brain Stimulation Plus Drug Fights Depression: Study
9. Tree-Savers™ Reports Successful Launch of Private St Beetle Lab; 100,000 Predator Beetles Now Available to Fight HWA Infestation
10. Scientists identify new strategy to fight deadly infection in cystic fibrosis
11. Bacterial supplement could help young pigs fight disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: